Eriodictyol-7-O-glucoside
Modify Date: 2025-08-23 18:37:33
Eriodictyol-7-O-glucoside structure
|
Common Name | Eriodictyol-7-O-glucoside | ||
|---|---|---|---|---|
| CAS Number | 38965-51-4 | Molecular Weight | 450.393 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 841.0±65.0 °C at 760 mmHg | |
| Molecular Formula | C21H22O11 | Melting Point | 171-176ºC | |
| MSDS | USA | Flash Point | 296.9±27.8 °C | |
Use of Eriodictyol-7-O-glucosideEriodictyol-7-O-glucoside (Eriodictyol 7-O-β-D-glucoside), a flavonoid, is a potent free radical scavenger. Eriodictyol-7-O-glucoside is also an Nrf2 activator, confers protection against Cisplatin-induced toxicity[1]. |
| Name | eriodictyol-7-glucoside |
|---|---|
| Synonym | More Synonyms |
| Description | Eriodictyol-7-O-glucoside (Eriodictyol 7-O-β-D-glucoside), a flavonoid, is a potent free radical scavenger. Eriodictyol-7-O-glucoside is also an Nrf2 activator, confers protection against Cisplatin-induced toxicity[1]. |
|---|---|
| Related Catalog | |
| Target |
Nrf2[1] |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 841.0±65.0 °C at 760 mmHg |
| Melting Point | 171-176ºC |
| Molecular Formula | C21H22O11 |
| Molecular Weight | 450.393 |
| Flash Point | 296.9±27.8 °C |
| Exact Mass | 450.116211 |
| PSA | 186.37000 |
| LogP | 0.22 |
| Vapour Pressure | 0.0±3.3 mmHg at 25°C |
| Index of Refraction | 1.713 |
| InChIKey | RAFHNDRXYHOLSH-TUYHZEGRSA-N |
| SMILES | O=C1CC(c2ccc(O)c(O)c2)Oc2cc(OC3OC(CO)C(O)C(O)C3O)cc(O)c21 |
| Storage condition | 2-8°C |
| Safety Phrases | 22-24/25 |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Two new hepatoprotective stilbene glycosides from Acer mono leaves.
J. Nat. Prod. 68 , 101-3, (2005) Two new stilbene glycosides, 5-O-methyl-(E)-resveratrol 3-O-beta-d-glucopyranoside (1) and 5-O-methyl-(E)-resveratrol 3-O-beta-D-apiofuranosyl-(1-->6)-beta-d-glucopyranoside (2), were isolated from th... |
|
|
Eriodictyol-7-O-glucoside, a novel Nrf2 activator, confers protection against cisplatin-induced toxicity
Food Chem. Toxicol. 50 , 1927-1932, (2012) Graphical abstract Eriodictyol-7-O-glucoside was identified as a novel Nrf2 activator and the present study demonstrated the efficacy of the compound in battling cisplatin-induced toxicity. [Display o... |
| 3',4',5,7-Tetrahydroxyflavanone-7-glucoside |
| ERIODICTYOL-7-GLUCOSIDE |
| (2S)-2-(3,4-Dihydroxyphényl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxyméthyl)tétrahydro-2H-pyran-2-yl]oxy}-2,3-dihydro-4H-chromén-4-one |
| pyracanthoside |
| eriodictyol-7-O-glucoside |
| (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl β-D-glucopyranoside |
| 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(β-D-glucopyranosyloxy)-2,3-dihydro-5-hydroxy-, (2S)- |
| (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-2,3-dihydro-4H-chromen-4-one |
| (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-2,3-dihydro-4H-chromen-4-on |
| (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl-β-D-glucopyranoside |
| (S)-2-(3,4-Dihydroxyphenyl)-7-(b-D-glucopyranosyloxy)-2,3-dihydro-5-hydroxy-4H-1-benzopyran-4-one |